CoChat

The effect of cirrhosis on the disposition and elimination of meperidine in man

Klotz, U., McHorse, T. S., Wilkinson, G. R., Schenker, S. · 1974 · Clinical Pharmacology & Therapeutics
Cited by 165

The DOI matches its Crossref record.

Abstract

The disposition and elimination of meperidine were compared in drug and alcohol‐free, age‐matched groups of 8 normal volunteers and 10 patients with cirrhosis of the liver, while controlling the urinary pH at 7.0 or more. After a single rapid intravenous injection, 0.8 mg/kg, plasma meperidine concentration declined biexponentially with the fast (α) and slow (ß) phases having half‐lives in the normal group of 0.19 hr and 3.2 hr (mean values), respectively. In the cirrhotics T½α was not changed but T½ß increased to 7.0 hr (p < 0.001), and this was associated with a reduction in the total plasma meperidine clearance from 1,316 ml/min to 664 ml/min (p < 0.002). Analysis of the data by a two‐compartment open model indicated that meperidine was extensively distributed; initial distribution volume (V 1)2 1.54 lIkg and volume of distribution at steady‐state (Vd ss), 4.17 lIkg in control subjects. Similar volumes of distribution were noted in cirrhotic patients. The overall first‐order elimination rate constant, k 13, decreased from 0.672 hr‐1 in the normal subjects to 0.242 hrs in the cirrhotics (p < 0.001). The plasma binding (64.3%) and the blood/plasma concentration ratio (0.683) of meperidine in control subjects were not altered in cirrhosis. There were no Significant correlations found between T½ß or plasma clearance in the cirrhotics and the usual biochemical hepatic function tests. The metabolite, normeperidine, was not detected in the plasma of either group. It is concluded that the elimination of meperidine is prolonged in cirrhosis, probably due to impairment of drug‐metaboliZing activity in the liver. Accordingly, caution should be exercised when this drug is administered, particularly for long periods, to patients with cirrhosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cpt1974164667

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Klotz, U., McHorse, T. S., Wilkinson, G. R., & Schenker, S.
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
1974-10
Volume
16
Issue
4
Pages
667-675
ISSN
  • 0009-9236 (ISSN-L)
  • 1532-6535
OpenAlex
W2428713294
Cited by
165
References
0
FWCI
11.90
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.